N@N

Niusule Biotech Corporation Retains Strategic Growth International, Inc. as Global Investor Relations Advisor

^{Published on 2010-06-08 06:50:19 - Market Wire}
 

MONROVIA, CA--(Marketwire - June 8, 2010) - Niusule Biotech Corp. (OTCBB: [ NIUS ]) (the Company), a fast growing China-based company offering animal health products as well as nutraceutical supplements for humans, today announced it has retained Strategic Growth International, Inc. ("SGI") as its investor relations consultant. SGI specializes in creating interest in undiscovered public companies worldwide and will assist the Company in establishing worldwide exposure, particularly with institutional investors.

According to Ms. Amy Hu, the Company's President and CEO, "We are very pleased that SGI has joined the Niusule Biotech team. This takes place during an important period of corporate growth for Niusule, as we continue to build out our extensive product portfolio, expand our marketing activities, and substantially increase our presence in China. We are pleased to be represented internationally by a major investor relations firm that is well known and respected by investors in leading growth-companies, particularly China-based. We believe that SGI's expertise will help us to identify institutions internationally that recognize the value of the competitive advantage of our products. We recognize SGI's global experience in leading healthcare companies like us. With the addition of SGI to our team, we believe that this will substantially enhance our position in the capital markets."

About Niusule Biotech Corp.
Niusule Biotech Corp is a bio-pharmaceutical company dedicated to offering high-quality pharmaceutical and nutritional supplement products to enhance both animal and human health. The Company has recently acquired a majority interest in Tianjin Behigh Pharmaceutical Co., Ltd, a veterinary drug and feed additives manufacturing company that produces injections, tablets, granules, oral solutions, powder, pelvis, and disinfectant for animal use. For the human product line, Niusule currently has a retail distribution network throughout China comprised of 124 outlets at high-end supermarkets and shopping malls in Zhejiang province, Shanghai and Beijing. For more information about Niusule Biotech Corp, please visit [ www.niusule.com ].

About Strategic Growth International, Inc.
Founded in 1989, SGI has assembled an experienced team of Wall Street professionals to serve their clients. Since its inception in 1989, Strategic Growth has achieved an unparalleled level of success for over a hundred clients. Leading this account for SGI are Richard Cooper, Chairman, and Jennifer Zimmons, Managing Director.

Forward-LookingStatements
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue,""project,""expect" and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. Niusule Biotech Corp. does not assume any duty to publicly update or revise the material contained herein.